Initial bi atrial three-dimensional echocardiographic evaluation in non-valvular atrial fibrillation according to rhythm outcome at six month follow-up

窦性心律 心房颤动 医学 电复律 心脏病学 内科学 心脏复律 射血分数 心力衰竭
作者
Laurie Soulat-Dufour,Sylvie Lang,Stéphane Éderhy,Yann Ancédy,Anne-Sophie Beraud,Saroumadi Adavane-Scheublé,M Chauvet,Nadjib Hammoudi,Pascal Nhan,Magali Charbonnier,Franck Boccara,Alasdair Cohen
出处
期刊:Archives of Cardiovascular Diseases Supplements [Elsevier BV]
卷期号:11 (1): 55-55
标识
DOI:10.1016/j.acvdsp.2018.10.119
摘要

Two-dimensional left atrial (LA) size is an independent echocardiographic predictor of atrial fibrillation (AF) occurrence and recurrence. Our study aimed to evaluate LA and right atrial (RA) three-dimensional (3D) volumes at admission (M0) in patients with AF to define atrial remodeling according to rhythm outcome at 6 month follow-up (M6). 3D RA and LA parameters were assessed at M0 in patients admitted for AF: body surface area-indexed maximum 3D volume (Max 3D RA Voli, Max 3D LA Voli) and indexed minimum volume (Min 3D RA Voli, Min 3D LA Voli); atrial emptying fraction (3D RAEF, 3D LAEF) and atrial expansion index (3D RAEI, 3D LAEI). Forty-eight consecutive patients hospitalized for AF were prospectively included. Two groups were individualized according to rhythm outcome: successful cardio version (SuccCV) in 35(72.9%) patients including either spontaneous (n = 10) or electrical cardioversion (n = 25) (AF at M0 and sinus rhythm (SR) at M6); failure or contra indication to cardioversion (FailCV) in 13(27.1%) patients (AF at M0 and AF at M6). 3D echocardiographic evaluation from 41 patients at M0 found: – significantly upper Min 3D RA Voli, Min 3D LA Voli in group FailCV in comparison with SuccCV; – significantly lower 3D RAEF, 3D RAEI, 3D LAEF, 3D LAEI in group FailCV in comparison with SuccCV; – no significant differences regarding Max 3D RA Voli, Max 3D LA Voli between groups FailCV and SuccCV (Table 1). 3D atrial echocardiographic parameters could be useful to predict initial atrial remodelling in patients admitted for AF.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
我爱学习发布了新的文献求助10
2秒前
所所应助小木采纳,获得10
2秒前
3秒前
4秒前
ding应助lln90采纳,获得10
4秒前
小胡同学完成签到,获得积分10
4秒前
123发布了新的文献求助10
5秒前
彭于晏应助一颗橘子采纳,获得10
5秒前
慕青应助Singularity采纳,获得10
6秒前
WAGKY完成签到,获得积分10
6秒前
o海边风o完成签到,获得积分20
6秒前
凝芙完成签到,获得积分10
6秒前
hsa_ID发布了新的文献求助10
6秒前
JamesPei应助文文文采纳,获得10
6秒前
威廉兰尼斯特完成签到,获得积分10
6秒前
zll发布了新的文献求助10
7秒前
7秒前
幸运的科研小狗完成签到,获得积分10
7秒前
7秒前
8秒前
一只鲨呱发布了新的文献求助20
8秒前
吼吼哈哈完成签到,获得积分10
8秒前
Maestro_S发布了新的文献求助10
8秒前
酒酿梅子完成签到,获得积分10
9秒前
9秒前
10秒前
10秒前
10秒前
Maestro_S发布了新的文献求助10
12秒前
SciGPT应助科研通管家采纳,获得10
12秒前
乐乐应助科研通管家采纳,获得10
12秒前
12秒前
大模型应助科研通管家采纳,获得10
12秒前
星辰大海应助科研通管家采纳,获得10
12秒前
我是老大应助关美人儿采纳,获得20
12秒前
脑洞疼应助科研通管家采纳,获得10
12秒前
英姑应助科研通管家采纳,获得10
12秒前
kingwill应助科研通管家采纳,获得20
12秒前
李健应助科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6168730
求助须知:如何正确求助?哪些是违规求助? 7996426
关于积分的说明 16630766
捐赠科研通 5273979
什么是DOI,文献DOI怎么找? 2813579
邀请新用户注册赠送积分活动 1793314
关于科研通互助平台的介绍 1659250